Skip to main content

Celecoxib

NDC 0615-8572 · NCS HealthCare of KY, LLC dba Vangard Labs

Generic nameCelecoxib

Dosage formCAPSULE

RouteORAL

Active ingredient(s)CELECOXIB

Strength100 mg/1

Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]

Marketing categoryANDA

Packages

0615-8572-39 — 30 CAPSULE in 1 BLISTER PACK (0615-8572-39)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0591-3982 — Celecoxib, 0591-3983 — Celecoxib, 0591-3984 — Celecoxib, 0615-8571 — Celecoxib, 0904-7550 — Celecoxib, 0904-7551 — Celecoxib, 11788-112 — Celecoxib, 11788-113 — Celecoxib, 11788-114 — Celecoxib, 11788-115 — Celecoxib, 13668-307 — celecoxib, 13668-310 — celecoxib, 13668-441 — celecoxib, 13668-442 — celecoxib, 15370-501 — Celecoxib, 16714-731 — CELECOXIB, 16714-732 — CELECOXIB, 16714-733 — CELECOXIB, 16714-734 — CELECOXIB, 23155-963 — Celecoxib, +213 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels